pt141 nasal spray kit PT-141 (Bremelanotide) Therapy PT-141 Bremelanotide Nasal Spray |
Description
The safety of SCENESSE was evaluated in 3 randomized, multicenter, prospective, vehicle controlled clinical trials (Study CUV029, Study CUV030, and Study CUV039) involving 244 adult subjects with erythropoietic protoporphyria (EPP) without significant liver involvement
Scanning view
Statistical analysis Statistical analysis in this study uses SPSS version 25.0 for Windows (IBM Corporation, Armonk, NY, USA)
Hepatic steatosis presents with large droplets of fat vacuoles in the cytoplasm of hepatocytes
S2CID 262086894
